Citius Oncology Inc (CTOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 0 | 200 | 148 | 0 | 0 |
| Operating Income | -422 | -200 | -148 | N/A | N/A |
| Other Income | 579 | 816 | 760 | 0 | 0 |
| Pre-tax Income | 158 | 616 | 612 | 0 | 0 |
| Net Income Continuous | N/A | 616 | 612 | N/A | N/A |
| Net Income | $N/A | $616 | $612 | $N/A | $N/A |
| EPS Basic Total Ops | 0.02 | 0.07 | 0.07 | N/A | 0.00 |
| EPS Basic Continuous Ops | N/A | 0.26 | 0.25 | N/A | N/A |
| EPS Diluted Total Ops | 0.02 | 0.07 | 0.07 | N/A | 0.00 |
| EPS Diluted Continuous Ops | N/A | 0.26 | 0.25 | N/A | N/A |
| EBITDA(a) | $N/A | $-200 | $-148 | $N/A | $N/A |